Reason for request

Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.


Clinical Benefit


The actual benefit of NPLATE 250 μg and 500 μg is substantial.

Clinical Added Value


NPLATE 250 μg and 500 μg, powder for solution for injection, provides an important improvement in actual benefit (IAB II) in the context of fallback treatment in cases of chronic ITP among adults who have undergone splenectomy but are still refractory or who are unsuitable for splenectomy for which the usual treatments have failed.

Contact Us

Évaluation des médicaments

See also